Results 1 to 10 of about 11,541 (279)

Hyperleucinosis during infections in maple syrup urine disease post liver transplantation [PDF]

open access: goldMolecular Genetics and Metabolism Reports, 2021
Maple syrup urine disease (MSUD) is due to biallelic variants in one of the three genes: BCKDHA, BCKDHB, and DBT. Branched-chain alpha-ketoacid dehydrogenase complex deficiency and elevated leucine, valine, isoleucine and alloisoleucine in body fluids ...
Laura Guilder   +8 more
doaj   +4 more sources

Neonatal gene therapy achieves sustained disease rescue of maple syrup urine disease in mice [PDF]

open access: yesNature Communications, 2022
Maple syrup urine disease (MSUD) is a rare inborn error of metabolism, which is currently treated with life-long low-protein diet that can be challenging to maintain.
Clément Pontoizeau   +15 more
doaj   +3 more sources

Identification of gene mutations in six Chinese patients with maple syrup urine disease [PDF]

open access: yesFrontiers in Genetics, 2023
Background: Maple syrup urine disease (MSUD) is a rare autosomal recessive amino acid metabolic disease. This study is to identify the pathogenic genetic factors of six cases of MUSD and evaluates the application value of high-throughput sequencing ...
Lulu Li   +11 more
doaj   +3 more sources

Maple syrup urine disease decompensation misdiagnosed as a psychotic event [PDF]

open access: yesMolecular Genetics and Metabolism Reports, 2022
Maple syrup urine disease (MSUD) is an autosomal recessive metabolic disease resulting in impaired or absent breakdown of branched-chain amino acids (BCAA) valine, isoleucine, and leucine.
Tomoyasu Higashimoto   +4 more
doaj   +3 more sources

Maple syrup urine disease: mechanisms and management

open access: yesThe Application of Clinical Genetics, 2017
Patrick R Blackburn,1,2,* Jennifer M Gass,1,* Filippo Pinto e Vairo,3,4,* Kristen M Farnham,5 Herjot K Atwal,6 Sarah Macklin,5 Eric W Klee,3,4,7,8 Paldeep S Atwal1,5 1Center for Individualized Medicine, 2Department of Health Sciences Research, Mayo ...
Blackburn PR   +7 more
doaj   +6 more sources

Pregnancy in an adolescent with maple syrup urine disease: Case report [PDF]

open access: yesMolecular Genetics and Metabolism Reports, 2021
Maple syrup urine disease (MSUD, MIM #248600) is an autosomal recessive metabolic disorder that results in elevation of the branched-chain amino acids (BCAA) leucine, isoleucine, and valine.
Michelle E. Abadingo   +3 more
doaj   +3 more sources

PERAWATAN GIGI PADA ANAK DENGAN MAPLE SYRUP URINE DISEASE (LAPORAN KASUS) [PDF]

open access: yesJournal of Dentistry Indonesia, 2015
Maple Syrup Urine Disease is a disparity of leusin decarboxilation, and isoleusin of valin defect that is synthesized with complex enzyme systems. It is a rare disease and represents disparity.
Tri Fajari, Ismu Suharsono Suwelo
doaj   +3 more sources

Neonatal maple syrup urine disease case report and literature review. [PDF]

open access: yesMedicine (Baltimore), 2022
Rationale: The main clinical symptoms of maple syrup urine disease (MSUD) are dehydration, acidosis, nervous system symptoms and intellectual disability. The brain imaging findings were mainly caused by cytotoxic edema.
Liu Q   +5 more
europepmc   +2 more sources

Genotypic and phenotypic spectrum of maple syrup urine disease in Zhejiang of China. [PDF]

open access: yesQJM
Background Maple syrup urine disease (MSUD) is an autosomal recessive metabolic disorder originating from defects in the branched-chain α-ketoacid dehydrogenase (BCKDH) complex encoded by BCKDHA, BCKDHB and DBT.
Yang X   +12 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy